
Will you ignore the "Shades of Enron?"
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

Will you ignore the "Shades of Enron?"

A 61-year-old woman has her entire $340,000 life savings sitting in a savings account earning 4.2%, and her child can’t understand why she won’t put at least some of it into an index fund. The answer comes back every time:...

A recent lawsuit surrounding a self-driving car crash that claimed a life has consumers questioning whether or not Tesla is really ready to roll out its new Cybercabs.

The president's repeated calls for lower interest rates are falling on deaf ears amid elevated inflation that's primarily been driven by his policies.

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

<body><p>STORY: From U.S. debt soaring higher to Walmart's rare sales miss...this is the Week in Numbers. </p><p>:: The Week in Numbers </p><p>:: $40 trillion</p><p>$40 trillion is how high total U.S. debt hit for the first time.</p><p>It drew warnings from analysts a fiscal crisis is developing.</p><p>That as growing costs for social safety-net programs and interest payments far exceed revenues held back by tax cuts.</p><p>U.S. debt has more than doubled in less than a decade, from just under $20 trillion when President Donald Trump was sworn in for the first time in January 2017.</p><p>:: 10%</p><p>As much as 10% is how far Walmart shares sank after its latest results.</p><p>The retail giant announced quarterly sales growth was well below analyst expectations.</p><p>Reuters Correspondent Nicholas Brown.</p><p>“Walmart's sales grew only 2.6% which is the the slowest pace of growth in about six years for them. It's the first time that they've met failed to meet analyst estimates for their sales in about five years. So, it's exceedingly rare for Walmart to miss.” </p><p>The company said shoppers were likely being squeezed by high gasoline prices, raising concerns pressure on U.S. consumers is growing. </p><p>:: 160%</p><p>Around 160% is how high Moderna shares soared this week.</p><p>Investors bought in after the drugmaker and Merck announced a successful cancer treatment.</p><p>They said a personalized mRNA cancer vaccine lowered the risk of recurrence and spread of melanoma in a late-stage trial.</p><p>Moderna said thousands of patients could benefit as soon as next year if regulators approve the vaccine.</p><p>:: $50 billion</p><p>And $50 billion is how much Chinese robotics firm Unitree was valued on its Shanghai stock debut.</p><p>The firm is one of the world's biggest producers of humanoid and quadruped robots. </p><p>Unitree has drawn global attention for its robots that run, dance and perform martial arts and become a source of national pride in China.</p><p>It isn't the first Chinese humanoid robot maker to go public, but its debut is expected to kick off a range of domestic rivals preparing to come to market. </p></body>

Style Box ETF report for IWS

Aug 21 (Reuters) - U.S. stock index futures inched up on Friday following a battering in the last session, in a week that saw elevated government bond yields and heightened geopolitical tensions weigh

National Highway Traffic Safety Administration said on Friday it has opened a probe into 997,743 General Motors pickup trucks and SUVs over concerns related to engine failure. The vehicles include the Cadillac Escalade, Chevrolet Silverado 1500 and GMC Yukon, among others, from model years 2021-2026 equipped with GM's L87 engines.

Stock futures were rising Friday, putting the market on track to claw back some of its losses after bond yields’ move higher sparked a selloff the previous session. Nasdaq 100 futures gained 0.6%. Dow Jones Industrial Average futures added 165 points, or 0.3%.

Editor’s Note: The story has been refreshed with the latest market price action and a revised headline. Elon Musk said Wednesday that mRNA technology could fundamentally change how diseases are treated, a shift that would make medicine more of a...

Aug 21 (Reuters) - Global equity funds drew their largest weekly inflows in three weeks through August 19 as investors bet on a strong earnings season, though rising bond yields and oil prices began
Meta Platforms (META), Alphabet's (GOOGL) Google and Snap (SNAP) face one fewer teen social media ad
Cerebras executives’ lock-up remains in effect until November, with the tax-related sales permitted under the lock-up.

U.S. stocks fell yesterday, with the Dow closing down nearly 700 points, more than 1%. Walmart slumped 9% percent after the retailer reported its smallest sales gain in more than six years as some Americans continue to spend cautiously.

AU, OZK and COLB have been added to the Zacks Rank #5 (Strong Sell) List on August 21st, 2026.

D-Wave Quantum (QBTS) shares drew fresh attention after the company appointed Kevan P. Krysler as an independent Class I director, adding long-tenured finance and audit expertise to its board and Audit Committee. See our latest analysis for D-Wave Quantum. The board appointment and recent Canadian funding news come after a mixed stretch for D-Wave Quantum, with the share price down 10.05% over the past week and 33.17% year to date, but a very large 3-year total shareholder return signals that...

The software titan experienced record revenue as it embraced the AI threat.

SELLAS Life Sciences Group, Inc. reported second-quarter 2026 results showing a net loss of US$9.61 million and basic loss per share from continuing operations of US$0.05, with first-half 2026 net loss reaching US$18.01 million and basic loss per share of US$0.10. Despite wider net losses in dollar terms, the company’s loss per share narrowed year on year, pointing to the impact of share count changes amid heightened interest in its Phase 3 GPS cancer vaccine program following positive...

He was known as one of the world’s best investors, until he got smacked down by the financial crisis. But almost 20 years later, his ideas and legacy resonate strongly.

SELLAS Life Sciences Group (SLS) is drawing fresh attention as investors reassess immune based cancer therapy stocks following Moderna and Merck’s Phase 3 cancer vaccine update and the broader oncology rally it helped spark. See our latest analysis for SELLAS Life Sciences Group. At a latest share price of $13.40, SELLAS Life Sciences Group has seen a 72.24% 90 day share price return and a very large 1 year total shareholder return. This suggests momentum has been building as attention shifts...

SELLAS Life Sciences Group stock has posted a very large 3 year return while the latest valuation checks flag it as expensive rather than a clear bargain. Over the past 3 years, SELLAS Life Sciences Group has delivered a gain of about 7.9x, which sets a high bar for any further upside to be justified. Progress toward key milestones in the REGAL AML trial and the advancement of SLS009 in difficult cancer indications can support high growth expectations, yet the usual risks around clinical...

South Korea plans to create a new fund to channel tax windfalls from the country's semiconductor boom into supporting younger generations and invest in future growth industries such as artificial intelligence, the budget ministry said on Friday. The proposed "Future Response Fund" would finance programmes aimed at helping young people find jobs, buy homes and start families, while also supporting investments in AI, regional development and talent development, according to a ministry press release. The fund would be financed mainly by tax revenue exceeding a benchmark based on the average growth in domestic tax receipts over the past decade.

The car parts provider is facing a "volatile demand environment."

Zscaler (ZS) shares came under pressure after a Bloomberg report suggested Anthropic is targeting an IPO size comparable to SpaceX’s record debut. This refocused investors on how AI labs may compete with enterprise SaaS stocks. See our latest analysis for Zscaler. The latest 1 day share price return of Zscaler was down 5.23%, extending a 7 day decline of 7.03%. However, the 30 day share price return of 17.64% points to improving short term momentum against weaker year to date share price and...

Shares of luxury electric car manufacturer Lucid (NASDAQ:LCID) fell 4.8% in the afternoon session after surging oil prices and rising interest rates weighed on consumer affordability.

A number of stocks fell in the afternoon session after the White House pivoted its Iran strategy toward financial sanctions, signaling a de-escalation of military options. President Donald Trump announced the U.S. will launch "Economic Warfare and Isolation on an unprecedented scale" against Iran, CNBC reported.

A number of stocks fell in the afternoon session after surging oil prices and rising long-term interest rates stoked fears of a slowdown in industry orders.

The famed quantitative investment firm reduced its MU position despite the chipmaker’s powerful rally and growing exposure to the AI boom.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.